Cascadian Therapeutics Inc

NAS:CASC (USA)  
(Delisted) $ 10.02 0 (0%) 04:00 PM EST
At Loss
Market Cap:
$ 554.28M
Enterprise V:
$ 554.28M
Volume:
-
Avg Vol (2M):
-
Volume:
-
At Loss
Avg Vol (2M):
-

CASC Stock Institutional Ownership and Insider Ownership - Cascadian Therapeutics Inc

50.62
(Mil)
Shares Outstanding
53.38%
26.99 (Mil)
Institutional Ownership
9.8%
4.96 (Mil)
Insider Ownership 1
58.23%
29.4761 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Cascadian Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Cascadian Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders